Control groups appropriate for behavioral interventions.

Area of Science:

• Clinical Psychology
• Psychotherapy Research
• Medical Research Methodology

Background:

• Clinical trials commonly encounter four bias sources: investigator bias, patient expectation, ascertainment bias, and non-specific effects.
• Standard drug trial controls (active vs. placebo, randomization, blinding) are often insufficient for behavioral interventions.

Purpose of the Study:

• To identify and address the unique challenges in conducting clinical trials for behavioral and psychological interventions.
• To propose methods for adequately controlling bias in these types of trials.

Main Methods:

• Addressing investigator blinding by using independent, blinded outcome assessors.
• Controlling for doctor-patient relationship variables using multiple, experienced therapists.
• Developing principles for selecting appropriate control treatments: plausibility and lack of impact on the intervention's presumed mechanism.

Main Results:

• The inability to blind experimenters can be managed with independent assessment.
• Doctor-patient effects can be controlled through therapist standardization.
• Appropriate control treatments must be credible yet inactive regarding the core therapeutic mechanism.

Conclusions:

• Behavioral intervention trials require specialized methods to mitigate bias effectively.
• Key strategies include blinded outcome assessment, standardized therapeutic relationships, and carefully selected control interventions.
• Validating control treatments involves assessing credibility, monitoring presumed mechanisms, and analyzing dropout rates.